TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Farmastat Norsk Legemiddelstatistikk AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,923
|
1,949
|
2,103 |
| Financial expenses |
11
|
7
|
1 |
| Earnings before taxes |
-42
|
3
|
85 |
| Total assets |
1,010
|
1,178
|
1,362 |
| Current assets |
607
|
761
|
828 |
| Current liabilities |
303
|
374
|
505 |
| Equity capital |
692
|
777
|
817 |
| - share capital |
178
|
190
|
201 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
68.5%
|
66.0%
|
60.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.2%
|
0.2%
|
4.0% |
| Return on assets (ROA) |
-3.1%
|
0.8%
|
6.3% |
| Current ratio |
200.3%
|
203.5%
|
164.0% |
| Return on equity (ROE) |
-6.1%
|
0.4%
|
10.4% |
| Change turnover |
98
|
-44
|
302 |
| Change turnover % |
5%
|
-2%
|
17% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.